Search Prime Grants

U54CA244711

Cooperative Agreement

Overview

Grant Description
Engineering the next generation of T cells.
Awardee
Trustees Of The University Of Pennsylvania
Funding Goals
TO PROVIDE SUPPORT FOR INITIATIVES FUNDED UNDER THE 21ST CENTURY CURES ACT TO SUPPORT CANCER RESEARCH, SUCH AS THE DEVELOPMENT OF CANCER VACCINES, THE DEVELOPMENT OF MORE SENSITIVE DIAGNOSTIC TESTS FOR CANCER, IMMUNOTHERAPY AND THE DEVELOPMENT OF COMBINATION THERAPIES, AND RESEARCH THAT HAS THE POTENTIAL TO TRANSFORM THE SCIENTIFIC FIELD, THAT HAS INHERENTLY HIGHER RISK, AND THAT SEEKS TO ADDRESS MAJOR CHALLENGES RELATED TO CANCER.
Grant Program (CFDA)
93.353 - 21st Century Cures Act - Beau Biden Cancer Moonshot
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Philadelphia, Pennsylvania 191045127 United States
Geographic Scope
Single Zip Code
Related Opportunity
Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed) (RFA-CA-19-013)
Analysis Notes
Amendment Since initial award the total obligations have increased 7% from $6,668,121 to $7,101,772.
Trustees Of The University Of Pennsylvania was awarded Engineering the Next Generation of T Cells Cooperative Agreement U54CA244711 worth $7,101,772 from National Cancer Institute in September 2019 with work to be completed primarily in Philadelphia Pennsylvania United States. The grant has a duration of 5 years and was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot. The Cooperative Agreement was awarded through grant opportunity Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed).

Status
(Complete)

Last Modified 1/6/25

Period of Performance
9/25/19
Start Date
8/31/24
End Date
100% Complete

Funding Split
$7.1M
Federal Obligation
$0.0
Non-Federal Obligation
$7.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA244711

Subgrant Awards

Disclosed subgrants for U54CA244711

Transaction History

Modifications to U54CA244711

Additional Detail

Award ID FAIN
U54CA244711
SAI Number
U54CA244711-457690302
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
GM1XX56LEP58
Awardee CAGE
7G665
Performance District
PA-03
Senators
Robert Casey
John Fetterman

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $13,813,095 100%
Modified: 1/6/25